Literature DB >> 24845579

Ulinastatin: is it worth using in severe sepsis?

Saurabh Saigal1, Garima Kapoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24845579     DOI： 10.1007/s00134-014-3341-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Albumin replacement in patients with severe sepsis or septic shock.

Authors:  Pietro Caironi; Gianni Tognoni; Serge Masson; Roberto Fumagalli; Antonio Pesenti; Marilena Romero; Caterina Fanizza; Luisa Caspani; Stefano Faenza; Giacomo Grasselli; Gaetano Iapichino; Massimo Antonelli; Vieri Parrini; Gilberto Fiore; Roberto Latini; Luciano Gattinoni
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

2.  A randomized trial of protocol-based care for early septic shock.

Authors:  Donald M Yealy; John A Kellum; David T Huang; Amber E Barnato; Lisa A Weissfeld; Francis Pike; Thomas Terndrup; Henry E Wang; Peter C Hou; Frank LoVecchio; Michael R Filbin; Nathan I Shapiro; Derek C Angus
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

3.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

4.  Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-01-04       Impact factor: 17.440

5.  Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study.

Authors:  Dilip R Karnad; Rakesh Bhadade; Pradeep K Verma; Nivedita D Moulick; Mradul K Daga; Neelima D Chafekar; Shivakumar Iyer
Journal:  Intensive Care Med       Date:  2014-04-16       Impact factor: 17.440
  5 in total
  3 in total

1.  An exciting candidate therapy for sepsis: ulinastatin, a urinary protease inhibitor.

Authors:  Adam Linder; James A Russell
Journal:  Intensive Care Med       Date:  2014-07-03       Impact factor: 17.440

2.  Ulinastatin did not reduce mortality in elderly multiple organ failure patients: a retrospective observational study in a single center ICU.

Authors:  Masatoshi Uchida; Toshikazu Abe; Kazuyuki Ono; Nanako Tamiya
Journal:  Acute Med Surg       Date:  2017-08-18

3.  Ulinastatin as an Adjuvant Therapy to Restricting Volumes of Resuscitation Fluid Strategy for Patients with Septic Shock after Initial Management.

Authors:  Rensong Dong; Xi Zhang; Zhi Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.